Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 15.02.2022.

#bionic
#HealthTech
#HealthIT
#biotech
#RareDisease
#SmartReviewer
#RSIDM22

Healthcare

@WSJhealth shared
On Feb 9, 2022
RT @Loftus: Western drugmakers wanted to bring to the U.S. medicines for cancer and other illnesses that had been largely developed in China. But the FDA appears to be tapping the brakes, concerned about the quality of testing. https://t.co/75SLXFh6oK via @WSJ
Open
FDA Raises Concerns About China-Developed Drugs

FDA Raises Concerns About China-Developed Drugs

The agency could slow the plans of big Western drugmakers to sell Chinese-tested medicines in U.S.

@HealthcareLdr shared
On Feb 14, 2022
RT @MargaretSiegien: Bionic eye tech aims to help blind people see #HealthIT #HealthTech #bionic @PawlowskiMario @Nicochan33 @tobiaskintzel @CurieuxExplorer @baski_LA @KanezaDiane https://t.co/tITmEdabcv
Open
Bionic eye tech aims to help blind people see

Bionic eye tech aims to help blind people see

Several firms are working on artificial eye tech that incorporates wireless, embedded sensors.

@SWLifeSciences shared
On Feb 9, 2022
Canadian Hedge Fund CIO Talks Top 2022 Prospects: https://t.co/faewV6EMGE AlphaNorth CIO Steven Palmer discusses emerging opportunities for 2022. $AGN.CA $AGNPF $MRK $BLU.CA $RHT.V $SOU.CA $FABL.CA @AlgernonPharma @Merck @BELLUSHealth @ReliqHealth @AlphaNorthAsset
Open
Canadian Hedge Fund CIO Talks Top 2022 Prospects

Canadian Hedge Fund CIO Talks Top 2022 Prospects

AlphaNorth Asset Management was recently recognized as the Number One equity hedge fund in Canada at the 2021 Alternative IQ Canadian Hedge Fund Awards due to its 5-year average investment ...

@GalapagosGlobal shared
On Feb 9, 2022
This community of #biotech industry leaders is proud to have launched its website today, showcasing their commitment to do well by doing good, for patients and society. Discover the website here👉 https://t.co/JxvdF5G1MO
Open
A new European Biotech Social Pact

A new European Biotech Social Pact

A new European Biotech Social Pact with Europe and Patients More than 80 industry CEOs and senior leaders from biotech and VCs have signed up to the Biotech Social Pact to demonstrate our ...

@eupatients shared
On Feb 10, 2022
RT @EatrisEric: We are pleased to see the new partnership between @EJPRareDiseases & @CPathInstitute that will benefit #RareDisease patients, regulators, advocacy stakeholders, researchers & industry. 👉 Find out more here: https://t.co/d7QTllaffu https://t.co/1JtVmxqh2h
Open
Press Release: EJP RD and C-Path to Expand Global Impact and Partnership

Press Release: EJP RD and C-Path to Expand Global Impact and Partnership

PARIS, France and TUCSON, Ariz., U.S., February 1st, 2022: The European Joint Programme on Rare Diseases (EJP RD) announces a collaboration with the Critical Path Institute …

@patrickflochel shared
On Feb 10, 2022
RT @PamelaSpence_EY: AI and machine learning are set to have a measurable impact on drug development, clinical trials, supply chain and commercial & regulatory processes. @arda_ph shares more on our new solution, EY #SmartReviewer: https://t.co/YTXf47EDDz
Open
How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

AI and ML are set to have a measurable impact on drug development, clinical trials, supply chain, and commercial and regulatory processes.

@Dominic_Tyer shared
On Feb 8, 2022
RT @endpts: A decade after the first-ever patients were infused with CAR-T, at least two of them remain cancer-free and their genetically modified cells still appear active, surveilling their blood for any budding malignancies that dare crop up. https://t.co/D3QjB6rNYL
Open
Carl June: ‘We can now conclude that CAR-T cells can actually cure patients’

Carl June: ‘We can now conclude that CAR-T cells can actually cure patients’

A decade after the first-ever patients were infused with CAR-T, at least two of them remain cancer free and their genetically modified cells still appear active, surveilling their blood for ...

@DrugInfoAssn shared
On Feb 14, 2022
DIA announces Brooke Casselberry, MSRA, as the 𝑬𝒙𝒄𝒆𝒍𝒍𝒆𝒏𝒄𝒆 𝒊𝒏 𝑺𝒆𝒓𝒗𝒊𝒄𝒆 𝑨𝒘𝒂𝒓𝒅𝒆𝒆! Learn more about Virtual #RSIDM22 learnings happening right now at https://t.co/ew6cs6LS1L 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴, 𝘉𝘳𝘰𝘰𝘬𝘦! https://t.co/Q2qSsVVqdJ
Open
Regulatory Submissions, Information, and Document Management Forum

Regulatory Submissions, Information, and Document Management Forum

Regulatory Submissions, Information, and Document Management Forum